4.7 Article

Total Flavones ofAbelmoschus manihotRemodels Gut Microbiota and Inhibits Microinflammation in Chronic Renal Failure Progression by Targeting Autophagy-Mediated Macrophage Polarization

期刊

FRONTIERS IN PHARMACOLOGY
卷 11, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.566611

关键词

chronic renal failure; total flavones ofAbelmoschus manihot; gut microbiota; microinflammation; autophagy; macrophage polarization

资金

  1. National Natural Science Foundation of China [81603675, 81573903]
  2. Natural Science Foundation of Jiangsu Province for Young Scholars [BK20161046]
  3. Priority Academic Program Development of Jiangsu Higher Education Institutions
  4. Open Projects of the Discipline of Chinese Medicine of Nanjing University of Chinese Medicine - Subject of Academic Priority Discipline of Jiangsu Higher Education Institutions [ZYX03KF016]
  5. Nanjing Medical Science and Technique Development Foundation [QRX17042]
  6. Nanjing Famous TCM Doctor's Studio Programme

向作者/读者索取更多资源

Background Recently, progression of chronic renal failure (CRF) has been closely associated with gut microbiota dysbiosis and intestinal metabolite-derived microinflammation. In China, total flavones ofAbelmoschus manihot(TFA), a component ofAbelmoschus manihot, has been widely used to delay CRF progression in clinics for the past two decades. However, the overall therapeutic mechanisms remain obscure. In this study, we designed experiments to investigate the renoprotective effects of TFA in CRF progression and its underlying mechanisms involved in gut microbiota and microinflammation, compared with febuxostat (FEB), a potent non-purine selective inhibitor of xanthine oxidase. Methods In vivo, the CRF rat models were induced by uninephrectomy, potassium oxonate, and proinflammatory diet, and received either TFA suspension, FEB, or vehicle after modeling for 28 days.In vitro, the RAW 264.7 cells were exposed to lipopolysaccharide (LPS) with or without TFA or FEB. Changes in parameters related to renal injury, gut microbiota dysbiosis, gut-derived metabolites, and microinflammation were analyzedin vivo. Changes in macrophage polarization and autophagy and its related signaling were analyzed bothin vivoandin vitro. Results For the modified CRF model rats, the administration of TFA and FEB improved renal injury, including renal dysfunction and renal tubulointerstitial lesions; remodeled gut microbiota dysbiosis, including decreasedBacteroidalesandLactobacillalesand increasedErysipelotrichales; regulated gut-derived metabolites, includingd-amino acid oxidase, serine racemase,d-serine, andl-serine; inhibited microinflammation, including interleukin 1 beta (IL1 beta), tumor necrosis factor-alpha, and nuclear factor-kappa B; and modulated macrophage polarization, including markers of M1/M2 macrophages. More importantly, TFA and FEB reversed the expression of beclin1 (BECN1) and phosphorylation of p62 protein and light chain 3 (LC3) conversion in the kidneys by activating the adenosine monophosphate-activated protein kinase-sirtuin 1 (AMPK-SIRT1) signaling. Further, TFA and FEB have similar effects on macrophage polarization and autophagy and its related signalingin vitro. Conclusion In this study, we demonstrated that TFA, similar to FEB, exerts its renoprotective effects partially by therapeutically remodeling gut microbiota dysbiosis and inhibiting intestinal metabolite-derived microinflammation. This is achieved by adjusting autophagy-mediated macrophage polarization through AMPK-SIRT1 signaling. These findings provide more accurate information on the role of TFA in delaying CRF progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据